ANDA User Fees: Complex Generics, Transparency, Communications Are Early Negotiation Targets

 
• By Sue Sutter
  
Wish list
The generic drug industry shared its wish list for GDUFA IV (Shutterstock)

More from Regulation

More from Policy & Regulation